JF
APLT

Jump Financial’s Applied Therapeutics APLT Stock Holding History

Jump Financial’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,122
Closed -$3.15K – 1755
2025
Q2 		$3.15K Buy
+10,122
New +$3.92K ﹤0.01% 1744
2024
Q3 		– Sell
-53,235
Closed -$249K – 1622
2024
Q2 		$249K Buy
53,235
+9,666
+22% +$45.7K 0.01% 1458
2024
Q1 		$296K Buy
43,569
+19,398
+80% +$87.1K 0.01% 1460
2023
Q4 		$81K Buy
+24,171
New +$60.2K ﹤0.01% 1682

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jump Financial's APLT Position: Q3 2025 in Review

Jump Financial sold out of Applied Therapeutics (APLT) in Q3 2025, closing a stake of 10,122 shares — an estimated $3.15K sold.

Jump Financial first reported a position in APLT in Q4 2023 and held it in 4 quarters. The position peaked at $296K in Q1 2024. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2025.

  • Jump Financial reported no remaining Applied Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 10,122 Applied Therapeutics shares in Q3 2025, an estimated $3.15K.
  • Jump Financial first reported a position in Applied Therapeutics in Q4 2023 and held it in 4 quarters.
  • Jump Financial's Applied Therapeutics position peaked at $296K in Q1 2024.
  • 70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.